Home
Groups
Pages
Marketplace
See More
Groups Pages Marketplace Events Blogs Funding Offers Courses
Sign In Sign Up
Night Mode
Neurofibromatosis and Schwannomatosis Therapeutics Market Forecast by Disease Type and Region
The global Neurofibromatosis and Schwannomatosis Therapeutics Market is set to experience robust expansion, growing from USD 1.1 billion in 2026 to USD 2.3 billion by 2036 at a Compound Annual Growth Rate (CAGR) of 7.7%. The market entered 2026 up from USD 1.0 billion in 2025, catalyzed by the approval of mirdametinib (GOMEKLI)—the second...
0 Comments ·0 Shares ·50 Views ·0 Reviews
Please log in to like, share and comment!